Skip to content
SEC filings edition: Friday, November 13, 2026 · 767 companies with filings Publisher's serviceBoardeon, your AI board · Hire your board →
Monday, November 16, 2026Every business day from SEC EDGAR
SEC EDGAR · Nov 13, 2026 1bankruptcies 11delisting notices 12late filings 43leadership changes 6IPO filings 199private raises 90earnings releases
Company page · CIK 1894525 · APUS

Apimeds Pharmaceuticals US, Inc.

Filing with the SEC SEC-reporting company Matawan, NJ NYSE
An email when it files something new with the SEC. Your account

What this means

  • Exchange listing at riskOn Apr 22, 2026 the company disclosed a notice from its exchange (Item 3.01). Exchanges usually give a period to regain compliance before delisting.
  • Change in controlOn Dec 2, 2025 the company reported a change in control (Item 5.01).
  • Net loss in 2025Net loss of $6M for the year (2024: −$1.4M).

What to do next

Guides from the Companies Daily newsroom, picked for what the register shows.

Financials from XBRL

Calendar-year frame20252024
Net income (loss)−$6M−$1.4M
Total assets$164M$13K
Total liabilities$10.8M$1.4M
Stockholders’ equity$153M−$1.4M
Cash and equivalents$1.6M$3K

From XBRL data the company filed with the SEC (data.sec.gov frames, US GAAP, US dollars). A frame aligns the fiscal year with the calendar year closest to it; this company’s fiscal year ends December 31. Check the annual report for the exact figures and periods.

Name as filed
Apimeds Pharmaceuticals US, Inc.
CIK
0001894525
Tickers
APUS
Kind of filer
SEC-reporting company
Emerging growth company
Status
Filing with the SEC
State of incorporation
Delaware
Business address
Matawan, New Jersey
Industry (SIC)
2834 · Pharmaceutical preparations
Industry: D · Manufacturing →
Fiscal year ends
December 31
Last annual report
10-K for the period ended Dec 31, 2025
Last quarterly report
10-Q for the quarter ended Jun 30, 2026
Bankruptcy reported
Not in our data
Last edition event
Oct 1, 2026

Filing history

Newest first: the filings we classify (8-K items, late filing notices, delistings, deregistration, IPO registrations, Schedule 13D, Form D, annual and quarterly reports), from Jan 1, 2023. All documents, including those we do not classify, are in the EDGAR filing index.

  • Director or officer change: CFO change
    Form 8-K · items 5.02, 9.01 · filed Oct 1, 2026 · filing
  • Directors or officers changed
    Form 8-K · items 1.01, 5.02, 9.01 · filed Sep 11, 2026 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2026
    Form 10-Q · filed Aug 14, 2026 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2026
    Form 10-Q · filed May 26, 2026 · filing
  • Late quarterly report notice: Quarterly report (10-Q) will be late
    Form NT 10-Q · filed May 15, 2026 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed May 5, 2026 · filing
  • Directors or officers changed
    Form 8-K · items 1.01, 5.02, 8.01, 9.01 · filed May 4, 2026 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2025
    Form 10-K · filed May 4, 2026 · filing
  • Notice of delisting or listing-rule failure
    Form 8-K · items 3.01, 9.01 · filed Apr 22, 2026 · filing
  • Late annual report notice: Annual report (10-K) will be late
    Form NT 10-K · filed Mar 31, 2026 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 5.03, 8.01, 9.01 · filed Mar 26, 2026 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 5.03, 8.01, 9.01 · filed Mar 25, 2026 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed Jan 2, 2026 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed Dec 10, 2025 · filing
  • Directors or officers changed
    Form 8-K · items 1.01, 2.01, 2.03, 3.02, 5.01, 5.02, 5.03, 7.01, 9.01 · filed Dec 2, 2025 · filing
  • Change in control
    Form 8-K · items 1.01, 2.01, 2.03, 3.02, 5.01, 5.02, 5.03, 7.01, 9.01 · filed Dec 2, 2025 · filing
  • Acquisition or disposal completed
    Form 8-K · items 1.01, 2.01, 2.03, 3.02, 5.01, 5.02, 5.03, 7.01, 9.01 · filed Dec 2, 2025 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 9.01 · filed Nov 18, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2025
    Form 10-Q · filed Nov 12, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2025
    Form 10-Q · filed Aug 19, 2025 · filing
  • Late quarterly report notice: Quarterly report (10-Q) will be late
    Form NT 10-Q · filed Aug 14, 2025 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed Jun 5, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2025
    Form 10-Q · filed May 20, 2025 · filing
  • Stake of 5% or more with intent to influence: Schedule 13D: stake of 5% or more
    Form SCHEDULE 13D · filed May 19, 2025 · filing
  • Late quarterly report notice: Quarterly report (10-Q) will be late
    Form NT 10-Q · filed May 15, 2025 · filing
  • IPO prospectus (424B4): Final prospectus (424B4)
    Form 424B4 · filed May 9, 2025 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2024
    Form 10-K · filed Apr 15, 2025 · filing
  • Late annual report notice: Annual report (10-K) will be late
    Form NT 10-K · filed Mar 31, 2025 · filing
  • IPO registration filed: Registration statement (S-1)
    Form S-1 · filed Sep 25, 2024 · filing